The hidden danger in Trump’s drug-price plan

National Security Commission on Emerging Biotechnology, China completed more than 7,100 clinical drug trials in 2024, compared with roughly 6,000 in the United States. China’s share of global clinical trials has grown from approximately 1% in 2009 to nearly 30% today, while America’s share has declined.

Chinese scientists now produce roughly 60% of continue reading …